Core Points - AbbVie, in collaboration with adMare BioInnovations, has launched the AbbVie Biotech Innovators Award to support innovation in Quebec's life sciences sector [1][2] - The award aims to assist early-stage biotechnology startups that align with AbbVie's therapeutic focus areas, including immunology, oncology, neuroscience, eye care, and aesthetics [2][3] - The selected startup will receive a year of laboratory and office space at the adMare Innovation Centre in Montreal, along with access to AbbVie's expertise and mentorship [3][9] Industry Impact - Quebec's life sciences and health technologies industry contributes $6.5 billion to the province's GDP, highlighting its significance in the regional economy [5] - adMare BioInnovations has a strong track record, having built 38 companies that have attracted $2.5 billion in risk capital and created around 1,000 jobs in Canada [8] - The initiative reflects a commitment to fostering a thriving biotech ecosystem in Quebec, aiming to accelerate the development of transformative therapies [4][9]